Found: 35
Select item for more details and to access through your institution.
Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion.
- Published in:
- Application of Clinical Genetics, 2015, v. 8, p. 69, doi. 10.2147/TACG.S72223
- By:
- Publication type:
- Article
Personalized medicine and treatment approaches in non-small-cell lung carcinoma.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2012, v. 5, p. 113, doi. 10.2147/PGPM.S24258
- By:
- Publication type:
- Article
First-in-human trial of an anti-5T4 antibody-monomethylauristatin conjugate, PF-06263507, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 3, p. 315, doi. 10.1007/s10637-016-0419-7
- By:
- Publication type:
- Article
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 52, doi. 10.1016/j.cllc.2021.08.012
- By:
- Publication type:
- Article
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 178, doi. 10.1016/j.cllc.2020.10.015
- By:
- Publication type:
- Article
Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Therapy-Related Acute Myelogenous Leukemia With an 11q23/MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 6, p. 438, doi. 10.3816/CLC.2009.n.082
- By:
- Publication type:
- Article
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40028-z
- By:
- Publication type:
- Article
Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3164, doi. 10.3390/cancers13133164
- By:
- Publication type:
- Article
Advances in Immune Checkpoint Inhibition for Patients With Lung Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 11, p. 655
- By:
- Publication type:
- Article
Managing Adverse Effects of Immunotherapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 5, p. 364
- By:
- Publication type:
- Article
Mesothelin, a novel immunotherapy target for triple negative breast cancer.
- Published in:
- 2012
- By:
- Publication type:
- Report
Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non‐Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 9, p. 2034
- By:
- Publication type:
- Article
A Rapid Method to Regenerate Piezoelectric Microcantilever Sensors (PEMS).
- Published in:
- Sensors (14248220), 2011, v. 11, n. 5, p. 5520, doi. 10.3390/s110505520
- By:
- Publication type:
- Article
Biomarker Testing in Lung Cancer—What Does It Mean?
- Published in:
- 2020
- By:
- Publication type:
- Opinion
CheckMate 227: Nivolumab + Ipilimumab vs Platinum-Doublet Chemotherapy as First-Line Treatment for Advanced Non--Small Cell Lung Cancer (NSCLC) with High Tumor Mutational Burden (TMB).
- Published in:
- Journal of Oncology Navigation & Survivorship, 2018, v. 9, p. 26
- By:
- Publication type:
- Article
Low Level of Blood CD4<sup>+</sup> T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell Lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor α-targeting antibody-drug conjugate, in patients with solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e843, doi. 10.1093/oncolo/oyae062
- By:
- Publication type:
- Article
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. 342, doi. 10.1093/oncolo/oyad335
- By:
- Publication type:
- Article
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1232, doi. 10.1634/theoncologist.2017-0133
- By:
- Publication type:
- Article
Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 700, doi. 10.1634/theoncologist.2016-0345
- By:
- Publication type:
- Article
ERBB family fusions are recurrent and actionable oncogenic targets across cancer types.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1115405
- By:
- Publication type:
- Article
Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 16, p. 3067, doi. 10.1002/cncr.34348
- By:
- Publication type:
- Article
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized controlled trials.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4867, doi. 10.1002/cncr.33142
- By:
- Publication type:
- Article
The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15779, doi. 10.3390/ijms242115779
- By:
- Publication type:
- Article
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
- Published in:
- Oncogenesis, 2021, v. 10, n. 3, p. 1, doi. 10.1038/s41389-021-00317-y
- By:
- Publication type:
- Article